Literature DB >> 24779313

DNR and ECMO: a paradox worth exploring.

Ellen Cowen Meltzer, Natalia S Ivascu, Joseph J Fins.   

Abstract

Extracorporeal membrane oxygenation (ECMO) provides continuous circulation and/or oxygenation to adults with cardiac failure, pulmonary dysfunction, or both. The technology is similar to the traditional heart-lung bypass machines used during surgical procedures, however ECMO may be used outside the confines of the operating room and for extended periods of time. This paper explores the complexities, both clinical and ethical, of a do-not-resuscitate (DNR) order for patients with cardiopulmonary failure on veno-arterial (VA-ECMO), a type of ECMO that provides resuscitation superior to the chest compressions that DNR is intended to prevent. Clinically, a DNR order has limited utility for patients on VA-ECMO and its presence can serve to create confusion. Symbolically, however, the designation may serve as a stepping-stone for surrogates facing difficult end-of-life decisions. The paper concludes by suggesting that it is prudent to avoid DNR discussions in the context of VA-ECMO

Entities:  

Mesh:

Year:  2014        PMID: 24779313

Source DB:  PubMed          Journal:  J Clin Ethics        ISSN: 1046-7890


  3 in total

1.  A Survey of Physicians' Attitudes toward Decision-Making Authority for Initiating and Withdrawing VA-ECMO: Results and Ethical Implications for Shared Decision Making.

Authors:  Ellen C Meltzer; Natalia S Ivascu; Meredith Stark; Alexander V Orfanos; Cathleen A Acres; Paul J Christos; Thomas Mangione; Joseph J Fins
Journal:  J Clin Ethics       Date:  2016

2.  Extracorporeal membrane oxygenation as a bridge to chemotherapy in an Orthodox Jewish patient.

Authors:  Ellen C Meltzer; Natalia S Ivascu; Cathleen A Acres; Meredith Stark; Richard R Furman; Joseph J Fins
Journal:  Oncologist       Date:  2014-08-05

Review 3.  Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient.

Authors:  David A Baran
Journal:  Curr Transplant Rep       Date:  2017-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.